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Abstract. 
 
Synaptotagmin II is a type I signal-anchor 
 
protein, in which the NH
 
2
 
-terminal domain of 60 resi-
dues (N-domain) is located within the lumenal space of 
the membrane and the following hydrophobic region 
(H-region) shows transmembrane topology. We ex-
plored the early steps of cotranslational integration of 
this molecule on the endoplasmic reticulum membrane 
and demonstrated the following: (a) The translocation 
of the N-domain occurs immediately after the H-region 
and the successive positively charged residues emerge 
from the ribosome. (b) Positively charged residues that 
follow the H-region are essential for maintaining the 
correct topology. (c) It is possible to dissect the lengths 
of the nascent polypeptide chains which are required 
for ER targeting of the ribosome and for translocation 
of the N-domain, thereby demonstrating that different 
nascent polypeptide chain lengths are required for 
membrane targeting and N-domain translocation. (d) 
The H-region is sufﬁciently long for membrane integra-
tion. (e) Proline residues preceding H-region are criti-
cal for N-domain translocation, but not for ER target-
ing. The proline can be replaced with amino acid with 
low helical propensity.
Key words: membrane topology • membrane protein 
• signal-anchor sequence • protein translocation • 
translocon
 
Introduction
 
Synaptotagmin II (Syt II)
 
1
 
 is an integral membrane pro-
tein which exists mainly on the synaptic vesicles in brain
and is thought to be involved in Ca
 
2
 
1
 
 regulated exocytosis
(Sudhof and Rizo, 1996; Fukuda and Mikoshiba, 1997;
Schiavo et al., 1998; Osborne et al., 1999). It is composed
 
of three domains: the NH
 
2
 
-terminal hydrophilic domain
of 60 amino acid residues (N-domain), the hydropho-
bic transmembrane region (H-region), and the following
 
COOH-terminal domain containing two C2-domains
(C-domain). Based on its similarity with Syt I, Syt II has
 
been assumed to show N
 
exo
 
/C
 
cyt
 
 topology, in which the
N-domain is in the lumenal space of the membrane and
the following C-domain is on the cytoplasmic side (Gep-
pert et al., 1991; Fukuda et al., 1994; Perin et al., 1991).
Almost all the membrane proteins on the secretory
pathway are cotranslationally integrated into the ER
membrane and are sorted to final destinations via vesicu-
lar transport. As the Syt II molecule is transported from
ER to the synaptic vesicles, it acquires various modifica-
tions; e.g., multiple-palmitoylation (Chapman et al., 1996;
Veit et al., 1996), the conversion of the N-linked sugar
chain to a complex form, and O-linked glycosylation
(Kida, Y., manuscript in preparation; Fukuda, M., manu-
script in preparation). The integration of membrane pro-
teins into the ER membrane is initiated by the signal se-
quences of nascent polypeptides. The signal sequence is
recognized by the signal recognition particle (SRP), which
targets the ribosomes to the ER membrane. It is released
from the SRP by the function of the SRP receptor on the
ER membrane, then the sequence enters into the mem-
brane (Walter and Johnson, 1994). The membrane in-
tegration processes proceed via the protein translocation
channel (so-called translocon), whose minimum components
have been elucidated to be the Sec61p-complex and the
translocating chain-associating membrane protein (Matlack
et al., 1998).
The signal sequences have been classified into three cat-
egories: signal peptide (SP), and type I and type II signal-
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anchor sequences (SA-I and SA-II sequences, respec-
tively). SP and the SA-II sequence mediate the trans-
location of their COOH-terminal side resulting in N
 
cyt
 
/C
 
exo
 
orientation, while the SA-I sequence mediates the translo-
cation of its NH
 
2
 
-terminal portion resulting in N
 
exo
 
/C
 
cyt
 
orientation (High and Laird, 1997; Sakaguchi, 1997). SP is
cleaved off by the signal peptidase in the lumenal side,
whereas the SA sequences are not cleaved off, and remain
responsible for membrane anchoring. The unique topo-
genic function of the SA-I sequence has been demon-
strated in various membrane proteins: in the superfamily
of microsomal cytochrome P450, in the NADPH cyto-
chrome P450 reductase (Kida et al., 1998), in various virus
proteins (Parks and Lamb, 1993), and in the NH
 
2
 
-terminal
portions of G-protein–coupled receptor proteins (Wallin
and von Heijne, 1995). Furthermore, internal SA-I se-
quences take part in the various situations of integration
of multispanning membrane proteins (Ota et al., 1998a,b).
Signal sequences basically consist of three distinct re-
gions: the NH
 
2
 
-terminal hydrophilic region, the central hy-
drophobic region (H-region), and the COOH-terminal po-
lar region (von Heijne, 1990). The ER targeting function
of the signal sequences is primarily determined by the
H-region, and the orientation is affected by the flanking
regions. Statistically, the H-regions of signal-anchor se-
quences (17–27 residues) are longer than those of signal
peptides (7–14 residues; Nilsson et al., 1994). The long
H-region tends to pull the NH
 
2
 
-terminal portion. Posi-
tively charged residues in the NH
 
2
 
-terminal flanking re-
gion and tight folding of the region prevent the trans-
location of the NH
 
2
 
-terminal side, so that the following
COOH-terminal side of the H-region should be translo-
cated through the membrane (Sakaguchi et al., 1992b;
Sakaguchi, 1997; Wahlberg and Spiess, 1997). Growing
polypeptide chains following the SP and SA-II sequences
enter into the translocon directly from the ribosomes. In
contrast, the NH
 
2
 
-terminal region of the SA-I sequence is
translocated after completion of the synthesis. We herein
focus on the unique process of posttranslational transloca-
tion of the NH
 
2
 
-terminal region during integration of the
SA-I sequence.
In this study, using the mouse Syt II as a model of SA-I
proteins, we explored the early process of membrane in-
tegration and estimated the minimum length of the na-
scent polypeptide chain whose N-domain is translocated
through the membrane. We demonstrated that the mem-
brane targeting of the ribosome and translocation of the
N-domain proceed at somewhat different chain lengths
and that positive charges at the end of the H-region play a
critical role in the translocation. We further suggest that
the proline residues between the N-domain and the H-region
play a key role in the translocation.
 
Materials and Methods
 
Materials
 
The preparations of rough microsomal membrane (RM; Walter and Blo-
bel, 1983) and rabbit reticulocyte lysate (Jackson and Hunt, 1983) were
carried out as previously described. RM was extracted with EDTA and
treated with 
 
S
 
.
 
 aureus
 
 nuclease (Roche) as described (Walter and Blobel,
1983). The plasmid DNAs were prepared using Wizard plus mini-preps
(Promega) from 2 ml overnight cultures of 
 
E
 
.
 
 coli
 
. Cycloheximide and
puromycin were purchased from Sigma.
Rabbit antiserum specific for the C-domain (anti–C-domain antibody)
was raised against the C2A-domain (amino acids 139–267) as previously
described (Fukuda et al., 1994). Antibody specific for N-domain (anti–
N-domain antibody) was raised against synthetic peptide as follows: a
peptide corresponding to the NH
 
2
 
-terminal 20 amino acids of mouse Syt II
(MRNIFKRNQEPNVAPATTTAC) was coupled to keyhole limpet
hemocyanin using the COOH-terminal artificial cysteine residue. Rabbit
antiserum to this peptide were prepared at Quality Controlled Biochemi-
cals, Inc. The antibody was partially purified by ammonium sulfate frac-
tionation as described previously (Fukuda and Mikoshiba, 1999) and then
affinity-purified by exposure to antigenic peptide bound to FMP acti-
vated-cellulofine beads according to the manufacturer’s instructions
(Seikagaku Co.). Antiserum for dog Sec61
 
a
 
 was raised against the peptide
corresponding to the NH
 
2
 
-terminal 15 amino acid residues.
 
Construction of Expression Plasmid
 
cDNA coding for mouse Syt II was isolated from the plasmid, pBlue-
script-Syt II (Fukuda et al., 1994) by polymerase chain reaction using the
following primers: 5
 
9
 
-TCGGAAGCTTCCTCTGCCACCATGAGAA-3
 
9
 
(initiation codon of Syt II is underlined) and 5
 
9
 
-TAGCTCTAGAT-
CACGTCAGTGTCC-3
 
9
 
. The obtained DNA fragment was digested with
XbaI and HindIII, and was then subcloned between the HindIII and XbaI
sites of pRc/CMV (Invitrogen) to obtain pSytII-03.
The N-glycosylation consensus site in the N-domain was disrupted as
shown in Fig. 1 to obtain pSytII-NG. AflII sites were generated at various
positions as indicated in Fig. 2. Positively charged residues flanking the
COOH terminus of the H-region were changed as shown in Fig. 3. Dele-
tions and mutations of the H-regions were made as shown in Fig. 4. Pro-
line residues between the N-domain and the H-region were changed as in-
dicated in Figs. 5 and 6. Deletion mutants within the N-domain were made
as shown in Fig. 6. To obtain 
 
D
 
1-21, a DNA fragment encoding the se-
quence from Met22 to the termination codon (HindIII/XbaI) of Syt II was
amplified by PCR, and subcloned into pRc/CMV (HindIII/XbaI). Other
site-directed mutagenesis was performed according to the method of
Kunkel (Kunkel, 1985). All the mutants were screened by restriction en-
zyme mapping and confirmed by DNA sequencing. The sequences of oli-
gonucleotides used and full construction details for each plasmid are avail-
able from the authors.
 
In Vitro Transcription, Translation, Enzyme 
Treatments, and Immunoprecipitation
 
Plasmids encoding the wild-type and mutated Syt II molecules were lin-
earized by EcoRI and transcribed with T7-RNA polymerase (Toyobo/
Takara) as previously described (Sakaguchi et al., 1992a). The obtained
mRNAs were translated in the reticulocyte lysate cell-free system either
in the absence or presence of RM. The translation reaction contained 100
mM KOAc, 1.0 mM Mg(OAc)
 
2
 
, 32% reticulocyte lysate, and 15.5 kBq/
 
m
 
l
EXPRESS protein-labeling mix (NEN). Aliquots of the translation mix-
ture were treated by endoglycosidase H (EndoH; NEB) at 37
 
8
 
C for 60 min
under denaturing conditions according to the manufacturer’s procedures.
Other aliquots were treated by 0.2 mg/ml proteinase K (Merck) in the
presence or absence of 1% Triton X-100 for 40 min at 10
 
8
 
C. After the in-
cubation, the reactions were terminated with 5% trichloroacetic acid.
For immunoprecipitation, the proteinase K reaction was terminated
with 20 mM phenylmethylsulfonylfluoride for 10 min at 10
 
8
 
C. Then the re-
action mixture (20 
 
m
 
l) was treated with 1% SDS at 96
 
8
 
C for 5 min and
then diluted to 1 ml with IP buffer (1% Triton X-100, 50 mM Tris-HCl
[pH 7.5], 150 mM NaCl, and 2 mM phenylmethylsulfonylfluoride). After
insoluble materials were removed by centrifugation, the solution was incu-
bated once for 30 min with protein A–Sepharose (Amersham-Pharmacia)
alone, and then unbound fraction was incubated with domain specific an-
tibodies and protein A–Sepharose at 4
 
8
 
C for 120 min. After the superna-
tant was removed, the protein A–Sepharose was washed twice with 1 ml
of IP-buffer and then extracted with sample buffer for SDS-PAGE.
Plasmids for the truncated mRNAs were linearized by AflII and were
then subjected to in vitro transcription. The obtained mRNAs were trans-
lated in the reticulocyte lysate cell-free system either in the absence or
presence of RM for 20–30 min according to the length. To stabilize the
translation intermediate of nascent peptidyl-tRNA on ribosomes, the re-
action was performed at 22
 
8
 
C as previously described (Borel and Simon,
1996). After the reaction was terminated by 2 mM puromycin or 2 mM cy- 
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cloheximide, the mixture was incubated further for 30 min to allow the
membrane integration and glycosylation to be completed.
 
High Salt Extraction of RM
 
15-
 
m
 
l aliquots of translation reactions were diluted to 50 
 
m
 
l, which was fi-
nally adjusted to 500 mM KOAc, 5 mM Mg(OAc)
 
2
 
, and 30 mM Hepes
(pH 7.4). The mixture was then layered onto a cushion of 100 
 
m
 
l contain-
ing 0.5 M sucrose in the same buffer. After centrifugation for 5 min at
50,000 rpm (Hitachi RP100AT2 rotor), the membrane pellet (P) was dis-
solved directly in SDS-PAGE sample buffer. Proteins in the supernatant
(S) were precipitated with 5% trichloroacetic acid.
 
Cross-linking and Immunoprecipitation
 
Cross-linking reaction with the hetero-bifunctional cross-linker, 
 
m
 
-male-
imidobenzoyl-
 
N
 
-hydroxysuccinimide ester (MBS) (Pierce) was performed
as follows: 1.3 
 
m
 
l of 100 mM MBS was added to a 25-
 
m
 
l translation mixture
and incubated on ice for 2 h. The reaction was quenched by 0.1 M glycine
and 5 mM 2-mercaptoethanol on ice for 10 min. The mixture was diluted
to 500 
 
m
 
l with IP-buffer. After incubation at 4
 
8
 
C for 30 min, insoluble ma-
terials were removed by centrifugation. The following procedure was per-
formed as described above section.
 
Alkaline Floatation
 
Membrane anchoring was examined by the alkaline floatation method es-
sentially as described (Ota et al., 1998b). In brief, a 25-
 
m
 
l aliquot of trans-
lation mixture was added to 25 
 
m
 
l of 0.2 M Na
 
2
 
CO
 
3
 
 and incubated for 30
min on ice. This alkaline mixture (50 
 
m
 
l) was mixed with 90 
 
m
 
l 2.5 M su-
crose and placed in a 500-
 
m
 
l ultracentrifugation tube. Then two sucrose
layers, 150 
 
m
 
l 1.25 M and 150 
 
m
 
l 0.25 M were overlaid on the alkaline mix-
ture. Both these sucrose cushions contained 0.1 M Na
 
2
 
CO
 
3
 
. After the tube
was centrifuged at 355,000 
 
g
 
 for 90 min (Hitachi RP100AT2 rotor), the
layers of 0.25 M sucrose and 1.25 M sucrose were recovered as a mem-
brane-bound fraction (M) and the bottom layer of 1.6 M sucrose was re-
covered as a soluble fraction (S). Proteins in each fraction were precipi-
tated with trichloroacetic acid.
 
Expression of Mutated Syt II in COS7 Cells
 
The expression plasmids, pSytII-03, pSytII-NG, and pSyt-AAA were
transfected into COS7 cells with Lipofect-AMINE (GIBCO BRL)
according to the manual supplied by the manufacturer. In brief, 2 ml Opti-
MEM (GIBCO BRL) containing plasmid DNA (4 
 
m
 
g) and Lipofect-
AMINE (12 
 
m
 
l) were added to COS7 cells in a 60-mm well. After incuba-
tion for 5 h under 10% CO
 
2
 
, the transfection mixture was removed and
4 ml DME (10% fetal calf serum) was added. After being cultured for
40–48 h, the cells were pulse-labeled with EXPRESS protein labeling mix
(NEN) for 30 min and were then lysed with 1.5% SDS. Syt II protein was
immunoprecipitated with anti–C-domain antibody as previously described
(Anderson and Blobel, 1983). Aliquots of the immuno-isolated proteins
were treated with EndoH.
 
Image Analysis
 
Proteins were analyzed by SDS-PAGE and visualized on a BAS-2000 or
FLA-2000 PhosphorImager (Fuji). Quantification was performed using
MacBAS software (Ver. 2.5.2, Fuji).
 
Results
 
N-Glycosylation of Mouse Syt II
 
There are four potential asparagine-linked glycosylation
sites (-N-X-S/T-) in the mouse Syt II molecule. To confirm
the lumenal location of the N-domain, the potential accep-
tor site in the N-domain was disrupted by a single amino
acid substitution of T34A (Fig. 1 A). The mutated and
wild-type Syt II molecules were expressed in the reticulo-
cyte lysate cell-free system (Fig. 1 B). When the wild-type
was synthesized in the absence of RM, a major band of 52
kD was detected (lane 1), whereas upon synthesis in the
presence of RM it gave a larger band of 55 kD in addition
to the 52 kD band (lane 2). The larger form disappeared
by the treatment with EndoH (lane 3), indicating that the
larger form is a glycosylated molecule. In contrast, the
T34A mutant did not give a larger form (lanes 4 and 5), in-
dicating that the point mutation causes a defect in glycosy-
lation.
The wild-type and mutant forms were expressed in
COS7 cells and pulse-labeled for 30 min, before being im-
munoprecipitated (Fig. 1 C). The wild-type molecule of 55
kD (lane 1) was shifted to 52 kD by the EndoH treatment
(lane 2). In contrast, the 52 kD band of the T34A mutant
was not affected by the treatment (lanes 3 and 4), indicat-
ing that the mutant was not glycosylated in the cultured
cells, either. Under this labeling condition, only the core-
glycosylated form was detected as a major molecular spe-
cies and further modifications of Syt II required prolonged
chase (data not shown). These data directly demonstrate
that Asn32 is the sole glycosylation site within mouse Syt
II and that the N-domain of 60 amino acid residues is lo-
cated within the ER lumen.
These data are consistent with the report that Syt I,
which shares 
 
.
 
80% sequence identity with Syt II, is glyco-
sylated within the N-domain (Perin et al., 1991). It has also
been suggested from the sequence alignment that rat Syt
II is glycosylated within the N-domain (Geppert et al.,
Figure 1. N-glycosylation of mouse Syt II. (A) Domain structure
of mouse Syt II and amino acid sequences around the potential
glycosylation site within the N-domain. The closed box indicates
the H-region. The numbers indicate those of the amino acid resi-
dues. The glycosylation site (underlined) was disrupted by a sin-
gle mutation of T34A (double underlined). (B) The wild-type
and mutated molecules were expressed in the reticulocyte lysate
cell-free system in the absence (2) or presence (1) of RM. After
the translation reaction, an aliquot was treated with EndoH un-
der the denaturing condition (1 lane). (C) Both molecules were
expressed in COS7 cells. The cells were pulse-labeled and then
the Syt II molecules were immunoprecipitated with rabbit anti-
body against the C-domain of Syt II. Aliquots of the immunopre-
cipitants were treated with EndoH (1 lanes). 
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1991). We used the mouse Syt II as a model of SA-I pro-
tein in the following experiments, since the N-domain is so
long that the nascent polypeptide being inserted into the
membrane can be readily detected.
 
Timing of Translocation of the N-Domain
 
To dissect the processes of the membrane targeting of ri-
bosomes and the translocation of the N-domain, nascent
Syt II-polypeptides of various lengths were synthesized in
the cell-free system by translating truncated mRNAs (Fig.
2 A). In this system, the RNAs transcribed from truncated
cDNA possess no in-frame termination codon, so that the
nascent polypeptides are retained on ribosomes as pepti-
dyl-tRNA. Each truncated molecule is named according to
the number of amino acid residues (e.g., Syt-105). The
truncated Syt-molecules gave major single bands (Fig. 2 B,
lanes 1, 4, 7, and 10, upward arrowhead). When they were
expressed in the presence of RM, the translation reaction
was terminated with either cycloheximide or puromycin.
Cycloheximide stabilizes the nascent polypeptide bound
on the ribosome as peptidyl-tRNA, but puromycin medi-
ates the release of the nascent polypeptide from the ribo-
some. Upon treatment with cycloheximide, Syt-105 was
not glycosylated and Syt-120 was only slightly glycosylated
(lane 5, downward arrowhead). In contrast, their glycosy-
lation efficiencies were improved after being released
from the ribosome by puromycin treatment (lanes 3 and
6). Syt-135 and Syt-200 were efficiently glycosylated even
when translation reactions were terminated with cyclohex-
imide (lanes 8 and 11). Puromycin treatment caused slight
mobility shift only in the case of Syt-135, but this was for
unknown reasons (lane 9). The results of quantification of
the same experiments indicate that Syt-120 and Syt-125 re-
leased from the ribosomes were glycosylated as efficiently
as the Syt-200 molecule (Fig. 2 C). These data indicate that
nascent Syt-120 and Syt-125 molecules on the ribosomes
are not integrated into the membrane until they are re-
leased by puromycin.
Since the glycosylation site is separated by 29 amino
acid residues from the H-region, the Syt II molecule show-
ing the transmembrane topology is expected to be effi-
ciently glycosylated (Nilsson and von Heijne, 1993; Popov
et al., 1997). Thus, we assumed the population of the gly-
cosylated form to correlate with the amounts of mem-
brane-integrated molecules. The glycosylation efficiency
of all the truncated constructs in the presence of cyclohex-
imide was quantified (Fig. 2 D). There is a threshold of the
Figure 2. Timing of cotranslational mem-
brane targeting and N-domain translocation.
(A) Template DNAs linearized at various
sites were transcribed in vitro. The synthe-
sized mRNAs do not possess a termination
codon so that the nascent polypeptides re-
main as peptidyl-tRNA and are not released
from the ribosomes. The polypeptide seg-
ments within the ribosomes are indicated by
closed ovals. The numbers in the names of the
constructs correspond to their length. The
hatched box indicates the H-region. (B) Gly-
cosylation of the truncated polypeptides in
vitro. The mRNAs were translated in vitro in
the absence (2) or presence (1) of RM. The
translation reaction was terminated by cyclo-
heximide (C) or puromycin (P). Throughout
all of the figures, upward and downward ar-
rowheads indicate the unglycosylated and gly-
cosylated polypeptides, respectively. (C) Ef-
fect of puromycin on N-domain translocation.
After treatment with either cycloheximide
(CHX) or puromycin (Puro), glycosylated
and unglycosylated forms were quantified by
image analysis and the efficiency (%) was cal-
culated by the formula: [glycosylated-form] 3
100/[glycosylated-form  1 unglycosylated
forms]. The experiments for each construct
were carried out more than three times and
the standard deviation is indicated by error
bars. (D) Titration of glycosylation efficiency
as a function of polypeptide length. The
threshold length for glycosylation is estimated
to be 127 residues. (E) Syt-125 is bound to membrane in a high-salt–resistant fashion. Translation mixtures were adjusted to a high-salt
condition, and then membrane precipitates (P) and supernatants (S) were separated by ultracentrifugation. The total translation prod-
ucts before separation are also shown (T). Where indicated (Puro), polypeptides were released by puromycin from ribosomes before
high-salt treatment. (F) Syt-125 is cross-linked with Sec61a. Translation mixtures were treated with heterobifunctional cross-linker
(MBS 1). After the reactions, aliquots were immunoprecipitated with anti-Sec61a antibody (IP 1). Dot indicates the cross-linked
polypeptide (lane 5). 
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length for the efficient N-domain translocation and the
value is 127 amino acid residues. Thus, it is concluded that
the nascent polypeptide takes transmembrane topology in
the very early phase of its protein synthesis; that is just af-
ter the H-region emerges from the ribosome, as shown in
Fig. 2 A.
To investigate the membrane targeting of the nascent
polypeptides, we conducted high-salt extraction and cross-
linking experiments. After the translation, the membranes
were treated with the high-salt buffer (500 mM KOAc),
and separated into a membrane pellet and supernatant
(Fig. 2 E). Almost all the Syt-105 molecules were recov-
ered within the soluble fraction irrespective of the puro-
mycin treatment (Fig. 2 E, lanes 3 and 6). However, the
unglycosylated form of Syt-125 was largely recovered
within the membrane fraction (Fig. 2 E, lane 8). Upon puro-
mycin treatment, it was efficiently glycosylated, and the
glycosylated Syt-125 was also recovered within the mem-
brane fraction (Fig. 2 E, lane 11). Syt-200 was glycosylated
and membrane-bound, irrespective of puromycin release
(Fig. 2 E, lanes 14 and 17). When the translation product
of Syt-125 was treated with heterobifunctional cross-linker
(MBS), a 60-kD band was newly observed (Fig. 2 F, lane 5,
dot). This band was immunoprecipitated with anti-Sec61
 
a
 
antiserum (Fig. 2 F, lane 6), but not with anti-TRAMp an-
tiserum (data not shown). The 60-kD band corresponds to
the summation of 20 kD of Syt-125 and 39 kD of Sec61
 
a
 
.
Even the uncross-linked Syt-125 was coimmunoprecipi-
tated (Fig. 2 F, lane 6). These immunoprecipitated bands
were not observed after the puromycin treatment (Fig. 2
F, lanes 11 and 12), or when Syt-105 and Syt-200 were used
either (lanes 3 and 9).
These results clearly indicate that the nascent polypep-
tide of Syt-125 on the ribosome is targeted to the mem-
brane, whereas its N-domain is not translocated through
the membrane (see Fig. 7) until it is released from the ri-
bosome by puromycin. Thus, it is suggested that N-domain
translocation requires a longer H-region emerging from
the ribosome than ER targeting does. On the other hand,
the Syt-105 molecule on the ribosome is not targeted
to the membrane, so that its N-domain would not be effi-
ciently translocated through the membrane, even when it
is released from the ribosome.
 
Requirement of the Lysine Cluster Following
the H-Region
 
There is a lysine-rich region just after the H-region of
mouse Syt II (Fig. 3 A). To check the possibility that these
positive charges determine the orientation of the H-region,
we made a mutant in which the eight lysine residues of this
region were replaced by seven asparagine and one serine
residues. The mutant as well as wild-type molecules were
expressed in vitro in the presence or absence of RM and
their membrane topologies were examined with protein-
ase K and endoglycosidase H (Fig. 3).
Upon proteinase K treatment of the product synthe-
sized in the presence of RM, the wild-type molecule gave
four major proteinase K–resistant bands (Fig. 3 B, lane 4).
When the membrane was solubilized with mild detergent,
only the 25-kD band (indicated by closed arrowhead)
among them was degraded but the other three polypep-
tides were not affected (lane 5). The 25-kD band was im-
munoprecipitated with anti–N-domain antibody (Fig. 3 C,
lane 2) and not with anti–C-domain antibody (Fig. 3 C,
lane 3), whereas the other three bands were reacted only
with the anti–C-domain antibody (Fig. 3 C, lanes 3 and 6).
Upon the EndoH treatment after the proteinase K treat-
ment, only the 25 kD band was shifted into a smaller one
Figure 3.  Positive charges following the H-region are essential
for SA-I topogenesis. (A) Construct in which eight lysine resi-
dues were mutated to neutral ones. Potential glycosylation sites
are indicated; one within the N-domain and three within the cyto-
plasmic domain. (B) The mutant was expressed in vitro. After
the translation reaction, aliquots were treated with EndoH, and
with ProK in the presence (1) or absence (2) of detergent (Tri-
ton X-100). One, two, and three dots indicate mono-, di-, and tri-
glycosylated polypeptides. Closed and open arrowheads indicate
membrane-protected N-domain and C-domain, respectively. An
asterisk indicates glycosylated ProK-resistant core fragment de-
rived from C-domain. (C) Immunoprecipitation of proteinase K
fragments with site-specific antibodies. After the proteinase K
treatment in the presence (1) or absence (2) of the detergent,
peptide fragments were immunoprecipitated with anti–N-domain
(IP, N) or anti–C-domain (IP, C) antibody. The total (IP, 2) and
the immunoprecipitated polypeptides were subjected for SDS-
PAGE. 
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(data not shown). It is, thus, indicated that the 25-kD band
is a membrane protected fragment containing the translo-
cated and glycosylated N-domain, and the other bands are
proteinase K–resistant core fragments derived from the
C-domain.
In contrast to the wild-type, when the positive charge
mutant was synthesized in the presence of RM, it gave
three glycosylated bands which were sensitive to EndoH
(Fig. 3 B, lanes 7 and 8). Upon proteinase K treatment,
smeared band(s) slightly smaller than the three glycosy-
lated bands were newly observed (Fig. 3 B, lane 9, open ar-
rowhead). This broad band(s) was immunoprecipitated
with anti–C-domain antibody and not with anti–N-domain
antibody (Fig. 3 C, lanes 8 and 9). It should be noted that
there is no substantial amount of the 25-kD band in the
fraction immunoprecipitated with anti–N-domain anti-
body (Fig. 3 C, lane 8). Upon proteinase K treatment in
the presence of Triton X-100, the broad band(s) disap-
peared and several proteinase K–resistant fragments were
newly observed (Fig. 3 C, lane 10). All of these bands were
immunoprecipitated with anti–C-domain antibody but not
with anti–N-domain antibody (Fig. 3 C, lane 11 and 12).
The EndoH treatment after the proteinase K treatment in
the presence of detergent resulted in the completely iden-
tical pattern as that obtained with wild-type molecule
(data not shown). Since Syt II has three glycosylation po-
tential sites within the C-domain, it is indicated that the
higher molecular weight bands in the lane 10 were glycosy-
lated and proteinase K–resistant core fragments derived
from the C-domain (Fig. 3 B, lane 10, asterisk). Taken to-
gether, these results demonstrated that the C-domain of
the 
 
D
 
8K mutant was translocated across the membrane
and glycosylated, and that its N-domain was on the cyto-
plasmic side. We concluded that the charge-mutation
caused complete inversion of the membrane topology.
We further examined effects of the N-domain lengths on
the requirement of the positive charges: neither deletions
of Met1-Thr21 nor Met46-Lys60 from the N-domain re-
sulted in any improvement of N-domain translocation of
 
D
 
8K mutant (data not shown). In contrast, when the
N-domain was replaced with the extracellular loop (of 39
residues long) of anion exchanger 1 (Ota et al., 1998a),
even the 
 
D
 
8K mutant showed mainly the SA-I orienta-
tion (data not shown). Thus, it is suggested that some un-
known characters (not solely the length) of the N-domain
cause the requirement of the positive charges following
the H-region.
 
Structural Requirements of the H-Region
 
To elucidate the length requirements of the H-region, we
constructed a series of mutants in which the H-region was
systematically shortened (Fig. 4 A). The constructs were
expressed in the cell-free translation system and their gly-
cosylation efficiencies were estimated. The mutants with
deletion of less than six residues were glycosylated as effi-
ciently as the wild-type molecule. Di- and tri-glycosylated
forms were not observed with any of these constructs
(data not shown). Thus, we concluded that the H-region of
Syt II possesses sufficient length for the SA-I topogenesis.
To further explore the structural features of the SA-I se-
quence of Syt II, we made a series of mutants in which the
amino acids in the H-region were systematically replaced
by those of rat cytochrome P450(2C11) (Fig. 4 B). Mi-
crosomal cytochrome P450s are SA-I proteins and form
large gene families (Omura et al., 1993). The H-region
from Met1 to Trp20 of cytochrome P450(2C11) has been
demonstrated to be sufficient for the function of SA-I
(Sakaguchi et al., 1987; Sato et al., 1990). Syt-06 with a
nonpolar segment of the same residue number as the wild-
type Syt II was integrated with the same efficiency,
whereas Syt-18 lacking the former sequence (IPLPPW)
could not be integrated. Similarly, Syt-08 which includes
the entire H-region of P450 was efficiently glycosylated,
whereas Syt-10 was hardly glycosylated at all. From these
observations, we realized that the H-region of the P450 is
not sufficient for the translocation of the Syt II N-domain
and that the stretch of 6 amino acid residues (IPLPPW) is
critical. Interestingly, in many Syt isoforms, the proline
residues are highly conserved between the N-domain and
the H-region (Fukuda et al., 1999; Li et al., 1995).
 
Critical Role of the Proline Residues
 
To elucidate the importance of the proline residues be-
tween the H-region and the N-domain, these prolines were
replaced to alanine residues (Fig. 5 A). The AAA mutant
Figure 4. Structural requirements of the H-region for SA-I topo-
genesis. (A) Effect of serial deletions of the H-region. The glyco-
sylation efficiencies were determined as described in the legend
to Fig. 2. (B) The effect of shuffling of the H-region of Syt II with
that of the rat cytochrome P450(2C11). The sequences of cyto-
chrome P450(2C11) are underlined. 
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in which all three proline residues were replaced by ala-
nines was not glycosylated (Fig. 5 B, lane 2), whereas mu-
tants having at least one proline residue were efficiently
glycosylated (lanes 3–5). The AAA mutant was not glyco-
sylated in the cultured cells, either (Fig. 5 C).
The membrane anchoring of the in vitro synthesized
AAA mutant was examined by extraction under the alka-
line condition (pH 11.5), which extracts almost all the pe-
ripheral membrane proteins (Fujiki et al., 1982). When the
wild-type molecule was incubated with RM after the trans-
lation termination, it was no longer glycosylated and little
was in the membrane fraction (Fig. 5 D, lane 5), indicating
that it was integrated into the membrane only in a cotrans-
lational fashion. When synthesized in the presence of RM,
a substantial amount of the AAA mutant was bound to
the membrane, although it was not glycosylated (Fig. 5 D,
lane 8). The membrane binding of the mutant was not ob-
served when it was incubated posttranslationally with RM
(Fig. 5 D, lane 11). The AAA mutant was integrated into
the membrane via hydrophobic interaction, probably form-
ing a loop structure.
The truncated form of the AAA mutant of NH
 
2
 
-termi-
nal 125 residues was recovered in a membrane pellet even
after the high-salt extraction, as observed with the wild-
type molecule (Fig. 5 E, lane 5). Furthermore, the trun-
cated form of the AAA mutant was cross-linked with
Sec61
 
a
 
 (Fig. 5 F, lane 5). This cross-linking was stage spe-
cific and not observed with the truncated polypeptides of
105 and 200 residues (Fig. 5 F, lanes 3 and 9). Interestingly,
coimmunoprecipitation with Sec61
 
a
 
 was also noted with
this mutant (Fig. 5 F, lane 6), indicating that the integra-
tion intermediate of Syt-125 mutant forms a stable complex
with the translocon. Taken together, we concluded that
the AAA mutant was as efficiently targeted to the ER
membrane as the wild-type and that at least one of the pro-
line residues is essential for translocation of the N-domain af-
ter the targeting process.
Since the regions flanking the proline residues were
predicted to form helix by the method of Chou and Fas-
man (Fig 6, A and B), there is the possibility that the pro-
line requirement may be important to disrupt a continuous
helix from the N-domain into the H-region. To examine
Figure 5. Proline residues between the N-domain and
the H-region are critical for SA-I topogenesis. (A) Pro-
line residues were mutated into alanine residues as indi-
cated. (B) The mutants were expressed in a cell-free
system in the presence of RM. The upward and down-
ward arrowheads indicate the unglycosylated and glyco-
sylated polypeptides, respectively. In the right panel,
the glycosylation efficiency of each construct was deter-
mined as described in the legend to Fig. 2. (C) The wild-
type and AAA mutant were expressed in the cultured
cells. The cells were pulse-labeled and Syt II molecules
were immunoprecipitated. Aliquots were further
treated by EndoH. (D) Membrane anchoring of the
AAA mutant. RM was added during translation reac-
tion (Co) or after the termination of the translation with
puromycin (Post). In the latter case (Post), the reaction
was continued for a further 30 min at 308C. The transla-
tion products were extracted with 0.1 M Na2CO3, and
then membrane-bound (M) and soluble (S) fractions
were separated by the alkaline floatation procedure.
Half equivalents of the total reactions are also shown
(T/2). (E) Membrane targeting of AAA mutant of 125
residues. The truncated mRNAs encoding 105 and 125
residues of the AAA mutant were translated in the
presence of RM and separated into membrane-bound
(P) and supernatant (S) fractions under the high-salt
condition. (F) Nascent polypeptide of 125 residues of
AAA mutant was cross-linked with Sec61a. After each
of the truncated mRNA was translated in the presence
of RM, cross-linking (MBS) and immunoprecipitation
(IP) were performed as in the legend to Fig. 2. 
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this possibility, we deleted most of the preceding region
which predicted to form helix (AAA
 
D
 
46-60). As expected,
this mutant was glycosylated as efficiently as the wild-type,
whereas the another mutant, AAA
 
D
 
1-21, in which the dis-
tal region had been deleted, was hardly glycosylated at all,
similar to the AAA mutant. Thus, it is suggested that the
proline residues are responsible for disrupting helix en-
compassing the H-region and the preceding 20 residues.
To directly examine the effect of the helical propensi-
ties, we introduced several kinds of amino acid residues
with different helical propensities into the third position
(Monne et al., 1999; Fig. 6 C). Asp and Lys residues with
low helical propensity in the third position could result the
efficient N-domain translocation as Pro residue. In con-
trast, Leu residue with high helical propensity could not
mediate efficient glycosylation as Ala residue, and Trp res-
idue with moderate helical propensity resulted in moder-
ate glycosylation. These results demonstrated that the he-
lical propensity of those amino acid residues are crucial for
determination of the fate of the N-domain. Together, it is
highly likely that the proline residing between the N-domain
and H-region is critical for breaking helix and for inducing
turn structure to mediate translocation of the N-domain.
Interestingly, it should be noted that it can be replaced
with Lys and Asp residues, despite their charges.
 
Discussion
 
The threshold value of the length of the Syt II nascent
polypeptide for the N-domain translocation is 127 residues
(Fig. 2). The positively charged residues just after the
H-region play an essential role in N-domain translocation
(Fig. 3). Since the 30–40 residues of the nascent polypep-
tide chain should be buried within the ribosome (Matlack
and Walter, 1995), the positively charged residues of the
nascent chain of 127 residues lie just at the exit site of the
ribosome upon translocation of the N-domain (Fig. 7).
The nascent polypeptides of Syt-120 and Syt-125 shorter
than the threshold are targeted to the ER membrane, so
that they are bound to the membrane in a salt-resistant
Figure 6. Effect of partial deletions of
the N-domain and replacement of the
third proline on N-domain translocation
of the AAA mutant. (A) N-domain of
the proline mutant (AAA) was par-
tially deleted as indicated. The mutated
proline residues and deleted amino acid
residues are indicated by a bold letter
and a dashed line, respectively. The
sequence predicted to form helix is
indicated by double underlining. The
mutants were expressed in a cell-free
system in the presence (1) or absence
(2) of RM. The upward and downward
arrowheads indicate the unglycosylated
and glycosylated polypeptides, respec-
tively. Glycosylation efficiencies were
determined as described in the legend
to Fig. 2. (B) Prediction of secondary
structure of the boundary between
N-domain and H-region. H, S, and T
correspond to the regions predicted as
helix, sheet, and turn, respectively.
H-region is indicated by underlines.
(C) The third proline residue was ex-
changed with amino acids with various
helical propensities. The glycosylation
efficiency was determined as described
in the legend to Fig. 2.Kida et al. Membrane Topogenesis of Synaptotagmin II 727
fashion and in the close proximity of Sec61a (Fig. 2).
These findings demonstrate that the polypeptide chain
length required for translocation of the N-domain and that
required for the ER targeting are different. The correct in-
tegration occurs only after the H-region and the successive
positive charges are fully exposed from the ribosome (Fig.
7). This consideration should be consistent with the two-
step recognition of the signal sequences. Some sequences
are sufficient for SRP recognition and for ER targeting,
but are not sufficient for further progress of membrane
translocation (Belin et al., 1996; Jungnickel and Rapoport,
1995). In the SA-I topogenesis, the progression of chain
elongation is essential for N-domain translocation after
the targeting step.
It has been proposed that the COOH terminus of the
H-region of SA-I sequence of the cytochrome P450 is initially
located in the lumenal side during SA-I topogenesis. This
is based on the observation that a cleavage site which had
been introduced to the COOH terminus of the H-region
of cytochrome P450 was partially cleaved by the signal
peptidase (Monier et al., 1988). However, the minor frac-
tion was processed while the majority fraction remained as
an unprocessed form showing SA-I topology in the experi-
ment, thus indicating that the Ncyt/Cexo transmembrane
form could not be an intermediate of SA-I topogenesis.
Considering the length between the P site of the ribosome
and the processing site (Whitley et al., 1996), Syt-127 is too
short to locate the COOH terminus of the H-region to the
active site of the signal peptidase (Fig. 7). Thus, it is highly
likely that the translocation of the N-domain occurs just
when the positive charges following the H-region interact
with a component of the translocon.
The nascent chain of Syt-105 was not targeted to ER
and glycosylation was inefficient even after release from
the ribosome. This suggests that the nascent polypeptide
should be targeted to ER as a ribosome complex for effi-
cient translocation of the N-domain. Upon further elonga-
tion, the nascent chain-ribosome complex is targeted to
the translocon, but its N-domain was still on the cytoplas-
mic side of the membrane. In this stage, Syt-125 is cross-
linked with Sec61a. This cross-linking is stage-specific,
since the chain elongation or puromycin treatment caused
a loss of reactivity. Thus, this stage is a bona fide produc-
tive intermediate of SA-I topogenesis. Interestingly, the
free Syt-125 molecule as well as the cross-linked one was
precipitated with anti-Sec61a antibody, indicating that the
intermediate is in a stable complex of the translocon.
The clustered positive charges beyond the H-region are
required for translocation of the N-domain (Fig. 3). These
positive charges should emerge from the ribosome and
should be recognized by components of the translocon. So
far, a systematic analysis of the SA-I sequences demon-
strated that the longer H-region and the less positive
charges in the N-domain prefer the SA-I topology (Sak-
aguchi et al., 1992b; Wahlberg and Spiess, 1997). The fold-
ing property of the N-domain is also a critical factor in the
topogenesis (Denzer et al., 1995). Furthermore, positive
charges at the COOH terminus of the stop-transfer se-
quence have been shown to possess an inhibitory effect on
the polypeptide chain translocation (Kuroiwa et al., 1990,
1991). In contrast to these findings, there is no clear obser-
vation showing the requirement of positive charges at the
COOH terminus of SA-I sequences. Although such a clus-
ter of positively charged residues has been frequently
noted following SA-I sequences of microsomal cyto-
chrome P450, we have shown that these positive charges
are not essential for the SA-I topogenesis (Sakaguchi et
al., 1987). The positive charges beyond the H-region were
also demonstrated to show no critical contribution in the
topological conversion between SA-II and SA-I sequences
(Parks and Lamb, 1991). In this case of Syt II, the N-domain
might contain some sequence(s) with a higher energy bar-
rier to be translocated through the translocon, so that even the
long H-region would not be sufficient to pull the N-domain
and the positive charges are required for fixation of the
COOH terminus of the H-region at the entrance of the
translocon. It is still an open question as to which compo-
nents of the translocon interact with these residues and
how these residues contribute to the movement of the
N-domain through the translocon.
The SA-I function of the hydrophobic segment was not
affected by the deletion of at most six residues from the
Figure 7. Working model for topogenesis
of the Syt II molecule. Syt-105 is not tar-
geted to the membrane (stage a). Syt-120
and Syt-125 are targeted to the membrane
but are not sufficient in length for N-domain
translocation (stage b). These are effi-
ciently chased with puromycin to be glyco-
sylated. For completion of the N-domain
translocation, further chain elongation is
essential so that the positively charged res-
idues beyond the H-region emerge from
the ribosome (stage c). Proline residues
between the N-domain and the H-region
are critical between stage b and stage d to
break continuous helix. The threshold of
the length for correct integration is 127
residues. The numbers indicate the num-
bers of amino acid residues of the nascent
polypeptide chains.The Journal of Cell Biology, Volume 150, 2000 728
hydrophobic segment (Fig. 4). Some extra residues are
thus required for the other functions, but not for mem-
brane integration. One possibility is that the length of the
TM is closely related to the intracellular location of mem-
brane proteins. The length and structure of the trans-
membrane segment has been demonstrated to be one
of the major determinants of intracellular location of
the COOH-terminal–anchored membrane proteins (Pe-
drazzini et al., 1996; Rayner and Pelham, 1997; Yang et al.,
1997), as well as SA-II proteins (Munro, 1995). The trans-
membrane segment of Syt II is much longer than those of
the microsomal cytochrome P450s; the H-regions of SA-I
of the microsomal P450 so far sequenced comprise ,20
amino acid residues. The transmembrane segments of
some P450 molecules have been actually demonstrated to
be sufficient for ER localization (Ahn et al., 1993; Mu-
rakami et al., 1994; Szczesna-Skorupa et al., 1995). The ef-
fects of the length of the H-region on the intracellular lo-
calization of Syt II are under investigation.
At least one residue of the proline between the
N-domain and the H-region is critical for translocation of
the N-domain (Fig. 5). The proline residues are often ob-
served within this region in many Syt isoforms (Fukuda et
al., 1999; Li et al., 1995) as well as within those in various
other species (not shown). The proline residue is not in-
volved in membrane targeting. As shown in Fig. 7, the turn
structure should be formed during translocation of the
N-domain. This notion is supported by the observation
that the proline requirement was not noted with the dele-
tion mutant that had lost its proximal region. Further-
more, the proline can be replaced with Asp and Lys that
are of low helical propensity, despite the charges, but not
with Leu and Ala with high helical propensity (Liu and
Deber, 1998; Monne et al., 1999). These observations sug-
gest that breaking helix is crucial for N-domain transloca-
tion.
In summary, we can dissect the membrane topogenesis
of SA-I protein as shown in the working model (Fig. 7).
Syt-105 is not targeted to the membrane, so that the
N-domain is inefficiently translocated even after it is re-
leased with puromycin (Fig. 7, stage a). Syt-120 and Syt-
125 are targeted to the membrane but are not sufficient in
length for integration, so that their N-domains are still on
the cytoplasmic side (stage b). These are efficiently chased
with puromycin, allowing them to be glycosylated (stage
c). The Syt II molecule of more than 127 residues was cor-
rectly integrated (stage d). For the completion of the
N-domain translocation, further chain elongation is essen-
tial so that the positively charged residues beyond the
H-region appear from the ribosome. The proline residues
between the N-domain and the H-region demonstrate a
critical function between stage b and stage d.
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